Hofmann S G, Shear M K, Barlow D H, Gorman J M, Hershberger D, Patterson M, Woods S W
Center for Anxiety and Related Disorders, Boston University, Massachusetts 02215-2002, USA.
Depress Anxiety. 1998;8(1):14-20.
Ninety-three patients with panic disorder and mild or no agoraphobia were treated for their panic disorder by using either 11 sessions of individual cognitive-behavior therapy or imipramine. Before and after treatment, their panic disorder symptomatology was assessed, and a self-report measure was administered to measure personality disorder characteristics [Klein et al., 1990: Wisconsin Personality Disorders Inventory]. In addition, some patients received this personality assessment again after six monthly maintenance sessions. Both treatments were equally effective in reducing panic disorder symptomatology, and both treatments had a positive influence on personality disorder characteristics. Personality disorder characteristics did not predict treatment outcome in either group. The implications of the findings for the assessment of personality and the treatment of panic disorder are discussed.
93名患有惊恐障碍且有轻度广场恐惧症或无广场恐惧症的患者，通过接受11次个体认知行为疗法或丙咪嗪治疗其惊恐障碍。治疗前后，对他们的惊恐障碍症状进行了评估，并采用一项自我报告测量来评估人格障碍特征[克莱因等人，1990年：威斯康星人格障碍量表]。此外，一些患者在接受6次每月一次的维持治疗后再次接受了这种人格评估。两种治疗方法在减轻惊恐障碍症状方面同样有效，且对人格障碍特征均有积极影响。人格障碍特征在两组中均不能预测治疗结果。文中讨论了这些研究结果对人格评估和惊恐障碍治疗的意义。
